Cargando…

Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study

Objective To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population based cohort study. Setting Data from the Hong Kong population based electronic medical records on the Clinical Data A...

Descripción completa

Detalles Bibliográficos
Autores principales: Man, Kenneth K C, Chan, Esther W, Ip, Patrick, Coghill, David, Simonoff, Emily, Chan, Phyllis K L, Lau, Wallis C Y, Schuemie, Martijn J, Sturkenboom, Miriam C J M, Wong, Ian C K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450015/
https://www.ncbi.nlm.nih.gov/pubmed/28566274
http://dx.doi.org/10.1136/bmj.j2350
_version_ 1783239869519101952
author Man, Kenneth K C
Chan, Esther W
Ip, Patrick
Coghill, David
Simonoff, Emily
Chan, Phyllis K L
Lau, Wallis C Y
Schuemie, Martijn J
Sturkenboom, Miriam C J M
Wong, Ian C K
author_facet Man, Kenneth K C
Chan, Esther W
Ip, Patrick
Coghill, David
Simonoff, Emily
Chan, Phyllis K L
Lau, Wallis C Y
Schuemie, Martijn J
Sturkenboom, Miriam C J M
Wong, Ian C K
author_sort Man, Kenneth K C
collection PubMed
description Objective To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population based cohort study. Setting Data from the Hong Kong population based electronic medical records on the Clinical Data Analysis and Reporting System. Participants 190 618 children born in Hong Kong public hospitals between January 2001 and December 2009 and followed-up to December 2015. Main outcome measure Hazard ratio of maternal antidepressant use during pregnancy and ADHD in children aged 6 to 14 years, with an average follow-up time of 9.3 years (range 7.4-11.0 years). Results Among 190 618 children, 1252 had a mother who used prenatal antidepressants. 5659 children (3.0%) were given a diagnosis of ADHD or received treatment for ADHD. The crude hazard ratio of maternal antidepressant use during pregnancy was 2.26 (P<0.01) compared with non-use. After adjustment for potential confounding factors, including maternal psychiatric disorders and use of other psychiatric drugs, the adjusted hazard ratio was reduced to 1.39 (95% confidence interval 1.07 to 1.82, P=0.01). Likewise, similar results were observed when comparing children of mothers who had used antidepressants before pregnancy with those who were never users (1.76, 1.36 to 2.30, P<0.01). The risk of ADHD in the children of mothers with psychiatric disorders was higher compared with the children of mothers without psychiatric disorders even if the mothers had never used antidepressants (1.84, 1.54 to 2.18, P<0.01). All sensitivity analyses yielded similar results. Sibling matched analysis identified no significant difference in risk of ADHD in siblings exposed to antidepressants during gestation and those not exposed during gestation (0.54, 0.17 to 1.74, P=0.30). Conclusions The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants. If there is a causal association, the size of the effect is probably smaller than that reported previously.
format Online
Article
Text
id pubmed-5450015
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-54500152017-06-08 Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study Man, Kenneth K C Chan, Esther W Ip, Patrick Coghill, David Simonoff, Emily Chan, Phyllis K L Lau, Wallis C Y Schuemie, Martijn J Sturkenboom, Miriam C J M Wong, Ian C K BMJ Research Objective To assess the potential association between prenatal use of antidepressants and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population based cohort study. Setting Data from the Hong Kong population based electronic medical records on the Clinical Data Analysis and Reporting System. Participants 190 618 children born in Hong Kong public hospitals between January 2001 and December 2009 and followed-up to December 2015. Main outcome measure Hazard ratio of maternal antidepressant use during pregnancy and ADHD in children aged 6 to 14 years, with an average follow-up time of 9.3 years (range 7.4-11.0 years). Results Among 190 618 children, 1252 had a mother who used prenatal antidepressants. 5659 children (3.0%) were given a diagnosis of ADHD or received treatment for ADHD. The crude hazard ratio of maternal antidepressant use during pregnancy was 2.26 (P<0.01) compared with non-use. After adjustment for potential confounding factors, including maternal psychiatric disorders and use of other psychiatric drugs, the adjusted hazard ratio was reduced to 1.39 (95% confidence interval 1.07 to 1.82, P=0.01). Likewise, similar results were observed when comparing children of mothers who had used antidepressants before pregnancy with those who were never users (1.76, 1.36 to 2.30, P<0.01). The risk of ADHD in the children of mothers with psychiatric disorders was higher compared with the children of mothers without psychiatric disorders even if the mothers had never used antidepressants (1.84, 1.54 to 2.18, P<0.01). All sensitivity analyses yielded similar results. Sibling matched analysis identified no significant difference in risk of ADHD in siblings exposed to antidepressants during gestation and those not exposed during gestation (0.54, 0.17 to 1.74, P=0.30). Conclusions The findings suggest that the association between prenatal use of antidepressants and risk of ADHD in offspring can be partially explained by confounding by indication of antidepressants. If there is a causal association, the size of the effect is probably smaller than that reported previously. BMJ Publishing Group Ltd. 2017-06-01 /pmc/articles/PMC5450015/ /pubmed/28566274 http://dx.doi.org/10.1136/bmj.j2350 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Research
Man, Kenneth K C
Chan, Esther W
Ip, Patrick
Coghill, David
Simonoff, Emily
Chan, Phyllis K L
Lau, Wallis C Y
Schuemie, Martijn J
Sturkenboom, Miriam C J M
Wong, Ian C K
Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
title Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
title_full Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
title_fullStr Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
title_full_unstemmed Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
title_short Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
title_sort prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450015/
https://www.ncbi.nlm.nih.gov/pubmed/28566274
http://dx.doi.org/10.1136/bmj.j2350
work_keys_str_mv AT mankennethkc prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT chanestherw prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT ippatrick prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT coghilldavid prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT simonoffemily prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT chanphylliskl prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT lauwalliscy prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT schuemiemartijnj prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT sturkenboommiriamcjm prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy
AT wongianck prenatalantidepressantuseandriskofattentiondeficithyperactivitydisorderinoffspringpopulationbasedcohortstudy